Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Adrenoleukodystrophy.

H W Moser¹, A Bergin, S Naidu

¹Kennedy Institute for Handicapped Children, Baltimore, Maryland.

Endocrinology and Metabolism Clinics of North America

|June 1, 1991

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Effect-directed analysis of ginger (Zingiber officinale) and its food products, and quantification of bioactive compounds via high-performance thin-layer chromatography and mass spectrometry.

Food chemistry·2017

Same author

Risk of Thyroid Cancer Among Solid Organ Transplant Recipients.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2017

Same author

Rasmussen's encephalitis presenting as focal cortical dysplasia.

Epilepsy & behavior case reports·2015

Same author

The impact of age and gender on papillary thyroid cancer survival.

The Journal of clinical endocrinology and metabolism·2012

Same author

Higher evening antiepileptic drug dose for nocturnal and early-morning seizures.

Epilepsy & behavior : E&B·2011

Same author

Effects of the thyromimetic agent diiodothyropropionic acid on body weight, body mass index, and serum lipoproteins: a pilot prospective, randomized, controlled study.

The Journal of clinical endocrinology and metabolism·2010

Same journal

Navigating Adrenal Disease: A Comprehensive, Practical Guide for the Clinician.

Endocrinology and metabolism clinics of North America·2026

Same journal

Adrenal Disorders in Pregnancy.

Endocrinology and metabolism clinics of North America·2026

Same journal

Diagnosis and Management of Adrenocortical Carcinoma.

Endocrinology and metabolism clinics of North America·2026

Same journal

Pheochromocytomas and Paragangliomas.

Endocrinology and metabolism clinics of North America·2026

Same journal

Hereditary Conditions Associated with Adrenocortical Carcinoma, Pheochromocytoma, and Other Adrenal Tumors: Genetic Testing and Management Recommendations.

Endocrinology and metabolism clinics of North America·2026

Same journal

Primary Bilateral Macronodular Adrenal Hyperplasia.

Endocrinology and metabolism clinics of North America·2026

See all related articles

X-linked adrenoleukodystrophy (ALD) is a metabolic disorder diagnosed by measuring very long chain fatty acids (VLCFAs). Early detection is crucial for genetic counseling and managing potential neurological decline and Addison disease.

Area of Science:

Biochemistry
Genetics
Endocrinology

Background:

X-linked adrenoleukodystrophy (ALD) is a genetic disorder affecting very long chain fatty acid (VLCFA) metabolism.
ALD is characterized by the accumulation of VLCFAs, leading to adrenal insufficiency (Addison disease) and progressive neurological damage.

Purpose of the Study:

To highlight the diagnostic methods for X-linked adrenoleukodystrophy (ALD).
To emphasize the importance of prompt diagnosis for genetic counseling and therapeutic intervention.

Main Methods:

Diagnosis involves measuring elevated VLCFA levels in plasma.
Prenatal diagnosis can be achieved through assays on cultured amniocytes or chorionic villus samples.

Main Results:

Related Experiment Videos

Increased VLCFA levels in plasma are indicative of ALD.
Prenatal diagnostic assays confirm ALD in fetal samples.

Conclusions:

Early and accurate diagnosis of ALD is essential.
Prompt diagnosis facilitates genetic counseling and timely initiation of therapies to mitigate neurological disability and Addison disease.